Keyphrases
United States
100%
Recipient Outcomes
100%
Kidney Transplant Recipients
100%
Deceased Donor Kidney Transplantation
100%
Pediatric Donor
100%
Alemtuzumab
100%
Immunosuppression Induction
100%
RATG
100%
Graft Survival
50%
Recipient Survival
50%
IL2RA
50%
Tacrolimus
33%
Mycophenolate
33%
Deceased Donor Kidneys
33%
Rejection Rate
33%
Payer Type
33%
Transplant Center
16%
Large Cohort
16%
Non-associated
16%
Random Effects
16%
Sex-related
16%
Outcome Disparities
16%
Allograft Survival
16%
Kidney Graft
16%
Multivariable Model
16%
HLA Antigens
16%
Induction Regimen
16%
Induction Immunosuppression
16%
Preemptive Kidney Transplantation
16%
Steroid Maintenance
16%
Immunological Risk
16%
Induction Type
16%
Immunology and Microbiology
Immunosuppression
100%
Alemtuzumab
100%
Tacrolimus
33%
Mycophenolic Acid
33%
HLA Antigen
16%
Allograft
16%